GSK

Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic

Rump business will focus solely on vaccines and prescription medications

Sanofi says trials point to potential of its vaccine booster candidate against main variants of concern

Company is planning to separate its consumer unit

Iseq in Dublin closes the session up 1.3%

Building and travel stocks struggle on Iseq

Twitter stock tanks after Elon Musk puts $44bn deal on hold, but Tesla stock rises

Bargain-hunters enter market after sell-off on economic worries

Iseq down 0.5% as travel and leisure names weaken

British drugmaker confirms guidance for year in which it will spin-off its consumer goods division

CRH drives 2% rise on Iseq as banks edge up

Strike backed by 86% of those balloted on below inflation pay offer would be first for top drugmaker

Only inpatients will have access to Paxlovid; sotrovimab deemed ineffective against BA.2

Tech stocks keep the Nasdaq riding high

Firm has been hit by Covid-19 restrictions and disputed payment in Germany

We list the top five courses and focus on a sample course from each college featured

Stocks have dropped almost 2% this week amid rising Russia-Ukraine tensions

Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications

Company says it will take two years to return to 2021 profitability level

Pharmaceuticals giant says profits fell by a fifth last year

Fallout from failed GSK unit bid dogs board as group prepares for results presentation

Pharmaceutical manufacturer to focus on cancer and immunology

Government agrees supply deal with GSK for injectable drug sotrovimab

Group to organise its business into five new divisions in move to ease investor concerns

Nelson Peltz has previously taken stake in rival consumer goods group Procter & Gamble

Joe Brennan: Behemoth has been struggling to grow its sales at same pace as rivals

Ryanair advances as oil stocks come off near two-year high

Investor dissent forces company to drop bid for GlaxoSmothKline’s consumer products unit

Flutter the best performers in Dublin as Davy reiterates ‘outperform’ recommendation

Irish shares static as activity remains subdued after Christmas

Analysts negative on potential deal’s impact on debt and what it indicates about management thinking

Cost of deal is three times annual budget usually in place for new drugs in Republic

Cabinet approves deal for €90m worth of anti-viral drugs to help fight coronavirus

Drugmakers hope to build on success of Covid vaccine

Drugmaker under pressure after two activist investors took stakes and challenged company strategy

German researchers find therapies less effective in lab tests

Campaign marks the second big FTSE 100 company that the hedge fund has targeted this year

Sotrovimab is effective against all 37 identified mutations in the spike protein, GSK says

Britain’s drug regulator has approved Xevudy treatment

Plaintiff will need to take medication for the rest of her life, High Court hears